Johnson & Johnson Announces Acceleration of its COVID-19 Vaccine Candidate;
Phase 1/2a Clinical Trial to Begin in Second Half of July
"What COVID-19 Has Taught Me": 7 Johnson & Johnson Researchers Reveal Lessons They've Learned From the Pandemic
From scientists working on a potential vaccine to medically trained employees who mobilized to the front lines to help treat patients, these men and women share what most resonates for them about the unique and devastating virus, both professionally and personally.
“Finding Hope in Science & Innovation” – Perspective from Paul Stoffels
In his latest LinkedIn article, J&J Chief Scientific Officer Paul Stoffels shares how this year’s BIO Digital conference is uniquely positioned to bring the global biotech community together to transform health for all.